Verizon (NYSE:VZ): After Verizon’s stock was weak following its acquisition of Vodafone’s (NASDAQ:VOD) Verizon Wireless stake, Canaccord expects it to rebound. The firm believes Verizon’s stronger growth outlook following the deal will entice more investors to buy the stock.
Theravance (NASDAQ:THRX): After Theravance reported positive data for a trial of its TD-4208 for chronic obstructive pulmonary disease, Stifel thinks companies other than GlaxoSmithKline (NYSE:GSK) will be interested in making strategic deals with Theravance. The firm keeps a $52 price target on the shares and gives Theravance a Buy rating.
Goodrich Petroleum (NYSE:GDP): Canaccord is positive on Goodrich’s leverage to Eagle Ford and the emerging Tuscaloosa Marine Shale, and that upside potential is too great to ignore. Shares are Buy rated with a $27 price target, up from $23.
FX Energy (NASDAQ:FXEN): Brean Capital raised its price target on FX Energy to $7.50 from $6.25 to reflect steady positive news flow from exploration activities and improving fundamentals for Polish natural gas. The firm believes the market is not pricing in any exploration success, while the company has had in excess of 80 percent success rate using 3-D. The shares are given a Buy rating.